BACKGROUND: The surgical management of mammary intraductal papilloma without atypia (IDP) identified at core-needle biopsy (CNB) is controversial. This study assessed the rate of upgrade to carcinoma at surgical excision (EXC). METHODS: This study identified women with a CNB diagnosis of intraductal papilloma without atypia or carcinoma at a cancer center between 2003 and 2013. Radiologic-pathologic concordance was assessed for all cases, and discordant cases were excluded. The radiologic and clinicopathologic features of patients with a CNB diagnosis of IDP were correlated with an upgrade to carcinoma at EXC. RESULTS: The study population consists of 189 women with 196 IDPs; 166 women (171 IDPs) underwent EXC. The upgrade rate was 2.3% (4 of 171). The upgraded lesions were 2 invasive lobular carcinomas and 2 cases of ductal carcinoma in situ (DCIS). One case of DCIS involved the residual IDP, whereas the other 3 carcinomas were ≥ 8 mm away. Twenty-four women (25 IDPs) did not undergo EXC and had stable imaging on follow-up (median, 23.5 months). CONCLUSIONS: The upgrade rate at EXC for IDPs diagnosed at CNB with radiologic-pathologic concordance was 2.3%. These findings suggest that observation is appropriate for patients with radiologic-pathologic concordant CNB yielding IDP, regardless of its size. Cancer 2016.
BACKGROUND: The surgical management of mammary intraductal papilloma without atypia (IDP) identified at core-needle biopsy (CNB) is controversial. This study assessed the rate of upgrade to carcinoma at surgical excision (EXC). METHODS: This study identified women with a CNB diagnosis of intraductal papilloma without atypia or carcinoma at a cancer center between 2003 and 2013. Radiologic-pathologic concordance was assessed for all cases, and discordant cases were excluded. The radiologic and clinicopathologic features of patients with a CNB diagnosis of IDP were correlated with an upgrade to carcinoma at EXC. RESULTS: The study population consists of 189 women with 196 IDPs; 166 women (171 IDPs) underwent EXC. The upgrade rate was 2.3% (4 of 171). The upgraded lesions were 2 invasive lobular carcinomas and 2 cases of ductal carcinoma in situ (DCIS). One case of DCIS involved the residual IDP, whereas the other 3 carcinomas were ≥ 8 mm away. Twenty-four women (25 IDPs) did not undergo EXC and had stable imaging on follow-up (median, 23.5 months). CONCLUSIONS: The upgrade rate at EXC for IDPs diagnosed at CNB with radiologic-pathologic concordance was 2.3%. These findings suggest that observation is appropriate for patients with radiologic-pathologic concordant CNB yielding IDP, regardless of its size. Cancer 2016.
Authors: Kiran Jakate; Marina De Brot; Frank Goldberg; Derek Muradali; Frances P O'Malley; Anna Marie Mulligan Journal: Am J Surg Pathol Date: 2012-04 Impact factor: 6.394
Authors: Martha Elizabeth Glenn; Alyssa D Throckmorton; John B Thomison; Robert S Bienkowski Journal: Ann Surg Oncol Date: 2014-10-15 Impact factor: 5.344
Authors: Monica Rizzo; Jared Linebarger; Michael C Lowe; Lin Pan; Sheryl G A Gabram; Leonel Vasquez; Michael A Cohen; Marina Mosunjac Journal: J Am Coll Surg Date: 2012-01-11 Impact factor: 6.113
Authors: So-Youn Jung; Han-Sung Kang; Youngmee Kwon; Sun Young Min; Eun-A Kim; Kyoung Lan Ko; Seeyoun Lee; Seok Won Kim Journal: World J Surg Date: 2010-02 Impact factor: 3.352
Authors: Paul S Weisman; Brian J Sutton; Kalliopi P Siziopikou; Nora Hansen; Seema A Khan; Erin I Neuschler; Stephen M Rohan; Julie M Franz; Megan E Sullivan Journal: Hum Pathol Date: 2013-11-06 Impact factor: 3.466
Authors: Sayee Kiran; Young Ju Jeong; Maria E Nelson; Alexander Ring; Meade B Johnson; Pulin A Sheth; Yanling Ma; Stephen F Sener; Julie E Lang Journal: J Surg Res Date: 2018-06-29 Impact factor: 2.192
Authors: Shahrzad Abbassi-Rahbar; Stephen Sack; Kelsey E Larson; Jamie L Wagner; Lyndsey J Kilgore; Christa R Balanoff; Onalisa D Winblad; Amanda L Amin Journal: Ann Surg Oncol Date: 2021-08-02 Impact factor: 5.344